Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.

Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...

Elevance Health (NYSE:ELV) traded higher in the premarket on Tuesday, a move attributed to comments made by the company's CFO ...

Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future ...

We recently compiled a list of the Top 10 Health Insurance Stocks To Buy. In this article, we are going to take a look at ...

Daneshvar Rohinton of iA Global Asset Management is expecting an economic realignment as many countries look at becoming more ...

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...

Shares of Elevance Health Inc. ELV shed 2.61% to $411.04 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.49% to 5,599.30 ...

In a regulatory filing, Elevance Health (ELV) disclosed that its officers will speak with investors over the next several weeks. During these ...

Meanwhile, a suit filed against Cigna in California says the insurer denied over 300,000 claims in two months—about 1.2 ...

Health insurers, including Cigna, Humana and Elevance Health, are tucking changes to DEI strategies and business risks into ...